Document Detail


Derangements of post-ischemic cerebral blood flow by protein kinase C delta.
MedLine Citation:
PMID:  20813167     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cerebral ischemia causes blood flow derangements characterized by hyperemia (increased cerebral blood flow, CBF) and subsequent hypoperfusion (decreased CBF). We previously demonstrated that protein kinase C delta (δPKC) plays an important role in hippocampal neuronal death after ischemia. However, whether part of this protection is due to the role of δPKC on CBF following cerebral ischemia remains poorly understood. We hypothesized that δPKC exacerbates hyperemia and subsequent hypoperfusion resulting in CBF derangements following ischemia. Sprague-Dawley (SD) rats pretreated with a δPKC specific inhibitor (δV1-1, 0.5 mg/kg) exhibited attenuation of hyperemia and latent hypoperfusion characterized by vasoconstriction followed by vasodilation of microvessels after 2-vessel occlusion plus hypotension measured by 2-photon microscopy. In an asphyxial cardiac arrest model (ACA), SD rats treated with δV1-1 (pre- and post-ischemia) exhibited improved perfusion after 24 h and less hippocampal CA1 neuronal death 7 days after ACA. These results suggest possible therapeutic potential of δPKC in modulating CBF and neuronal damage after cerebral ischemia.
Authors:
H W Lin; R A Defazio; D Della-Morte; J W Thompson; S V Narayanan; A P Raval; I Saul; K R Dave; M A Perez-Pinzon
Related Documents :
18439837 - Nimesulide as a promising neuroprotectant in brain ischemia: new experimental evidences.
12009727 - Improvement of rat liver function by energy repletion after the preservation period: im...
6775397 - Local cerebral blood flow following transient cerebral ischemia. ii. effect of arterial...
12483497 - Blood flow response in individuals with incomplete spinal cord injuries.
9106927 - Tumour blood flow influences combined radiation and doxorubicin treatments.
11482497 - Near infrared spectrophotometry reflects cerebral metabolism during hypothermic circula...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-09-09
Journal Detail:
Title:  Neuroscience     Volume:  171     ISSN:  1873-7544     ISO Abbreviation:  Neuroscience     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-08     Completed Date:  2011-02-17     Revised Date:  2011-12-21    
Medline Journal Info:
Nlm Unique ID:  7605074     Medline TA:  Neuroscience     Country:  United States    
Other Details:
Languages:  eng     Pagination:  566-76     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 IBRO. Published by Elsevier Ltd. All rights reserved.
Affiliation:
Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Asphyxia / complications
Brain / blood supply,  metabolism,  pathology
Brain Ischemia / pathology,  physiopathology*
Cell Survival / drug effects
Cerebrovascular Circulation*
Heart Arrest / etiology,  physiopathology
Hyperemia / prevention & control
Male
Microcirculation
Neurons / drug effects,  pathology
Protein Kinase C-delta / antagonists & inhibitors,  physiology*
Protein Transport
Rats
Rats, Sprague-Dawley
Grant Support
ID/Acronym/Agency:
NS054147-01/NS/NINDS NIH HHS; NS34773/NS/NINDS NIH HHS; NS45676-01/NS/NINDS NIH HHS; R01 NS034773-12/NS/NINDS NIH HHS; R01 NS045676-06/NS/NINDS NIH HHS; R01 NS054147-04/NS/NINDS NIH HHS; T32-NS007459-10/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
EC 2.7.11.13/Protein Kinase C-delta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possibl...
Next Document:  Ameliorative effect of Yokukansan on social isolation-induced aggressive behavior of zinc-deficient ...